Andrew M. Glazer, PhD

Andrew Glazer, PhD, is an Assistant Professor of Medicine in the Division of Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. He is a geneticist interested in understanding which mutations lead to rare Mendelian disease. He is especially interested in rare arrhythmia syndromes and understanding which variants can lead to these diseases. Dr. Glazer uses a variety of high-throughput in vitro methods such as automated patch clamping and deep mutational scans. His work has resulted in a consistent record of funding awards and publications.

Dr. Glazer has a strong commitment to mentorship, including underrepresented groups. During his graduate career he directly mentored three female undergraduates, who each entered medical/graduate school. As a postdoctoral fellow, he mentored an underrepresented minority undergraduate for three years.

Dr. Glazer also studies large patient biobank cohorts to understand the impact of variants on disease phenotypes. In 2020, he was awarded an NIH K99 grant.